Cargando…

Phenotype Algorithms for the Identification and Characterization of Vaccine-Induced Thrombotic Thrombocytopenia in Real World Data: A Multinational Network Cohort Study

INTRODUCTION: Vaccine-induced thrombotic thrombocytopenia (VITT) has been identified as a rare but serious adverse event associated with coronavirus disease 2019 (COVID-19) vaccines. OBJECTIVES: In this study, we explored the pre-pandemic co-occurrence of thrombosis with thrombocytopenia (TWT) using...

Descripción completa

Detalles Bibliográficos
Autores principales: Shoaibi, Azza, Rao, Gowtham A., Voss, Erica A., Ostropolets, Anna, Mayer, Miguel Angel, Ramírez-Anguita, Juan Manuel, Maljković, Filip, Carević, Biljana, Horban, Scott, Morales, Daniel R., Duarte-Salles, Talita, Fraboulet, Clement, Le Carrour, Tanguy, Denaxas, Spiros, Papez, Vaclav, John, Luis H., Rijneek, Peter R., Minty, Evan, Alshammari, Thamir M., Makadia, Rupa, Blacketer, Clair, DeFalco, Frank, Sena, Anthony G., Suchard, Marc A., Prieto-Alhambra, Daniel, Ryan, Patrick B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160850/
https://www.ncbi.nlm.nih.gov/pubmed/35653017
http://dx.doi.org/10.1007/s40264-022-01187-y
_version_ 1784719357714104320
author Shoaibi, Azza
Rao, Gowtham A.
Voss, Erica A.
Ostropolets, Anna
Mayer, Miguel Angel
Ramírez-Anguita, Juan Manuel
Maljković, Filip
Carević, Biljana
Horban, Scott
Morales, Daniel R.
Duarte-Salles, Talita
Fraboulet, Clement
Le Carrour, Tanguy
Denaxas, Spiros
Papez, Vaclav
John, Luis H.
Rijneek, Peter R.
Minty, Evan
Alshammari, Thamir M.
Makadia, Rupa
Blacketer, Clair
DeFalco, Frank
Sena, Anthony G.
Suchard, Marc A.
Prieto-Alhambra, Daniel
Ryan, Patrick B.
author_facet Shoaibi, Azza
Rao, Gowtham A.
Voss, Erica A.
Ostropolets, Anna
Mayer, Miguel Angel
Ramírez-Anguita, Juan Manuel
Maljković, Filip
Carević, Biljana
Horban, Scott
Morales, Daniel R.
Duarte-Salles, Talita
Fraboulet, Clement
Le Carrour, Tanguy
Denaxas, Spiros
Papez, Vaclav
John, Luis H.
Rijneek, Peter R.
Minty, Evan
Alshammari, Thamir M.
Makadia, Rupa
Blacketer, Clair
DeFalco, Frank
Sena, Anthony G.
Suchard, Marc A.
Prieto-Alhambra, Daniel
Ryan, Patrick B.
author_sort Shoaibi, Azza
collection PubMed
description INTRODUCTION: Vaccine-induced thrombotic thrombocytopenia (VITT) has been identified as a rare but serious adverse event associated with coronavirus disease 2019 (COVID-19) vaccines. OBJECTIVES: In this study, we explored the pre-pandemic co-occurrence of thrombosis with thrombocytopenia (TWT) using 17 observational health data sources across the world. We applied multiple TWT definitions, estimated the background rate of TWT, characterized TWT patients, and explored the makeup of thrombosis types among TWT patients. METHODS: We conducted an international network retrospective cohort study using electronic health records and insurance claims data, estimating background rates of TWT amongst persons observed from 2017 to 2019. Following the principles of existing VITT clinical definitions, TWT was defined as patients with a diagnosis of embolic or thrombotic arterial or venous events and a diagnosis or measurement of thrombocytopenia within 7 days. Six TWT phenotypes were considered, which varied in the approach taken in defining thrombosis and thrombocytopenia in real world data. RESULTS: Overall TWT incidence rates ranged from 1.62 to 150.65 per 100,000 person-years. Substantial heterogeneity exists across data sources and by age, sex, and alternative TWT phenotypes. TWT patients were likely to be men of older age with various comorbidities. Among the thrombosis types, arterial thrombotic events were the most common. CONCLUSION: Our findings suggest that identifying VITT in observational data presents a substantial challenge, as implementing VITT case definitions based on the co-occurrence of TWT results in large and heterogeneous incidence rate and in a cohort of patints with baseline characteristics that are inconsistent with the VITT cases reported to date. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40264-022-01187-y.
format Online
Article
Text
id pubmed-9160850
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-91608502022-06-02 Phenotype Algorithms for the Identification and Characterization of Vaccine-Induced Thrombotic Thrombocytopenia in Real World Data: A Multinational Network Cohort Study Shoaibi, Azza Rao, Gowtham A. Voss, Erica A. Ostropolets, Anna Mayer, Miguel Angel Ramírez-Anguita, Juan Manuel Maljković, Filip Carević, Biljana Horban, Scott Morales, Daniel R. Duarte-Salles, Talita Fraboulet, Clement Le Carrour, Tanguy Denaxas, Spiros Papez, Vaclav John, Luis H. Rijneek, Peter R. Minty, Evan Alshammari, Thamir M. Makadia, Rupa Blacketer, Clair DeFalco, Frank Sena, Anthony G. Suchard, Marc A. Prieto-Alhambra, Daniel Ryan, Patrick B. Drug Saf Original Research Article INTRODUCTION: Vaccine-induced thrombotic thrombocytopenia (VITT) has been identified as a rare but serious adverse event associated with coronavirus disease 2019 (COVID-19) vaccines. OBJECTIVES: In this study, we explored the pre-pandemic co-occurrence of thrombosis with thrombocytopenia (TWT) using 17 observational health data sources across the world. We applied multiple TWT definitions, estimated the background rate of TWT, characterized TWT patients, and explored the makeup of thrombosis types among TWT patients. METHODS: We conducted an international network retrospective cohort study using electronic health records and insurance claims data, estimating background rates of TWT amongst persons observed from 2017 to 2019. Following the principles of existing VITT clinical definitions, TWT was defined as patients with a diagnosis of embolic or thrombotic arterial or venous events and a diagnosis or measurement of thrombocytopenia within 7 days. Six TWT phenotypes were considered, which varied in the approach taken in defining thrombosis and thrombocytopenia in real world data. RESULTS: Overall TWT incidence rates ranged from 1.62 to 150.65 per 100,000 person-years. Substantial heterogeneity exists across data sources and by age, sex, and alternative TWT phenotypes. TWT patients were likely to be men of older age with various comorbidities. Among the thrombosis types, arterial thrombotic events were the most common. CONCLUSION: Our findings suggest that identifying VITT in observational data presents a substantial challenge, as implementing VITT case definitions based on the co-occurrence of TWT results in large and heterogeneous incidence rate and in a cohort of patints with baseline characteristics that are inconsistent with the VITT cases reported to date. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40264-022-01187-y. Springer International Publishing 2022-06-02 2022 /pmc/articles/PMC9160850/ /pubmed/35653017 http://dx.doi.org/10.1007/s40264-022-01187-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research Article
Shoaibi, Azza
Rao, Gowtham A.
Voss, Erica A.
Ostropolets, Anna
Mayer, Miguel Angel
Ramírez-Anguita, Juan Manuel
Maljković, Filip
Carević, Biljana
Horban, Scott
Morales, Daniel R.
Duarte-Salles, Talita
Fraboulet, Clement
Le Carrour, Tanguy
Denaxas, Spiros
Papez, Vaclav
John, Luis H.
Rijneek, Peter R.
Minty, Evan
Alshammari, Thamir M.
Makadia, Rupa
Blacketer, Clair
DeFalco, Frank
Sena, Anthony G.
Suchard, Marc A.
Prieto-Alhambra, Daniel
Ryan, Patrick B.
Phenotype Algorithms for the Identification and Characterization of Vaccine-Induced Thrombotic Thrombocytopenia in Real World Data: A Multinational Network Cohort Study
title Phenotype Algorithms for the Identification and Characterization of Vaccine-Induced Thrombotic Thrombocytopenia in Real World Data: A Multinational Network Cohort Study
title_full Phenotype Algorithms for the Identification and Characterization of Vaccine-Induced Thrombotic Thrombocytopenia in Real World Data: A Multinational Network Cohort Study
title_fullStr Phenotype Algorithms for the Identification and Characterization of Vaccine-Induced Thrombotic Thrombocytopenia in Real World Data: A Multinational Network Cohort Study
title_full_unstemmed Phenotype Algorithms for the Identification and Characterization of Vaccine-Induced Thrombotic Thrombocytopenia in Real World Data: A Multinational Network Cohort Study
title_short Phenotype Algorithms for the Identification and Characterization of Vaccine-Induced Thrombotic Thrombocytopenia in Real World Data: A Multinational Network Cohort Study
title_sort phenotype algorithms for the identification and characterization of vaccine-induced thrombotic thrombocytopenia in real world data: a multinational network cohort study
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160850/
https://www.ncbi.nlm.nih.gov/pubmed/35653017
http://dx.doi.org/10.1007/s40264-022-01187-y
work_keys_str_mv AT shoaibiazza phenotypealgorithmsfortheidentificationandcharacterizationofvaccineinducedthromboticthrombocytopeniainrealworlddataamultinationalnetworkcohortstudy
AT raogowthama phenotypealgorithmsfortheidentificationandcharacterizationofvaccineinducedthromboticthrombocytopeniainrealworlddataamultinationalnetworkcohortstudy
AT vossericaa phenotypealgorithmsfortheidentificationandcharacterizationofvaccineinducedthromboticthrombocytopeniainrealworlddataamultinationalnetworkcohortstudy
AT ostropoletsanna phenotypealgorithmsfortheidentificationandcharacterizationofvaccineinducedthromboticthrombocytopeniainrealworlddataamultinationalnetworkcohortstudy
AT mayermiguelangel phenotypealgorithmsfortheidentificationandcharacterizationofvaccineinducedthromboticthrombocytopeniainrealworlddataamultinationalnetworkcohortstudy
AT ramirezanguitajuanmanuel phenotypealgorithmsfortheidentificationandcharacterizationofvaccineinducedthromboticthrombocytopeniainrealworlddataamultinationalnetworkcohortstudy
AT maljkovicfilip phenotypealgorithmsfortheidentificationandcharacterizationofvaccineinducedthromboticthrombocytopeniainrealworlddataamultinationalnetworkcohortstudy
AT carevicbiljana phenotypealgorithmsfortheidentificationandcharacterizationofvaccineinducedthromboticthrombocytopeniainrealworlddataamultinationalnetworkcohortstudy
AT horbanscott phenotypealgorithmsfortheidentificationandcharacterizationofvaccineinducedthromboticthrombocytopeniainrealworlddataamultinationalnetworkcohortstudy
AT moralesdanielr phenotypealgorithmsfortheidentificationandcharacterizationofvaccineinducedthromboticthrombocytopeniainrealworlddataamultinationalnetworkcohortstudy
AT duartesallestalita phenotypealgorithmsfortheidentificationandcharacterizationofvaccineinducedthromboticthrombocytopeniainrealworlddataamultinationalnetworkcohortstudy
AT frabouletclement phenotypealgorithmsfortheidentificationandcharacterizationofvaccineinducedthromboticthrombocytopeniainrealworlddataamultinationalnetworkcohortstudy
AT lecarrourtanguy phenotypealgorithmsfortheidentificationandcharacterizationofvaccineinducedthromboticthrombocytopeniainrealworlddataamultinationalnetworkcohortstudy
AT denaxasspiros phenotypealgorithmsfortheidentificationandcharacterizationofvaccineinducedthromboticthrombocytopeniainrealworlddataamultinationalnetworkcohortstudy
AT papezvaclav phenotypealgorithmsfortheidentificationandcharacterizationofvaccineinducedthromboticthrombocytopeniainrealworlddataamultinationalnetworkcohortstudy
AT johnluish phenotypealgorithmsfortheidentificationandcharacterizationofvaccineinducedthromboticthrombocytopeniainrealworlddataamultinationalnetworkcohortstudy
AT rijneekpeterr phenotypealgorithmsfortheidentificationandcharacterizationofvaccineinducedthromboticthrombocytopeniainrealworlddataamultinationalnetworkcohortstudy
AT mintyevan phenotypealgorithmsfortheidentificationandcharacterizationofvaccineinducedthromboticthrombocytopeniainrealworlddataamultinationalnetworkcohortstudy
AT alshammarithamirm phenotypealgorithmsfortheidentificationandcharacterizationofvaccineinducedthromboticthrombocytopeniainrealworlddataamultinationalnetworkcohortstudy
AT makadiarupa phenotypealgorithmsfortheidentificationandcharacterizationofvaccineinducedthromboticthrombocytopeniainrealworlddataamultinationalnetworkcohortstudy
AT blacketerclair phenotypealgorithmsfortheidentificationandcharacterizationofvaccineinducedthromboticthrombocytopeniainrealworlddataamultinationalnetworkcohortstudy
AT defalcofrank phenotypealgorithmsfortheidentificationandcharacterizationofvaccineinducedthromboticthrombocytopeniainrealworlddataamultinationalnetworkcohortstudy
AT senaanthonyg phenotypealgorithmsfortheidentificationandcharacterizationofvaccineinducedthromboticthrombocytopeniainrealworlddataamultinationalnetworkcohortstudy
AT suchardmarca phenotypealgorithmsfortheidentificationandcharacterizationofvaccineinducedthromboticthrombocytopeniainrealworlddataamultinationalnetworkcohortstudy
AT prietoalhambradaniel phenotypealgorithmsfortheidentificationandcharacterizationofvaccineinducedthromboticthrombocytopeniainrealworlddataamultinationalnetworkcohortstudy
AT ryanpatrickb phenotypealgorithmsfortheidentificationandcharacterizationofvaccineinducedthromboticthrombocytopeniainrealworlddataamultinationalnetworkcohortstudy